1. What does GLP-1 clinic management software need to handle?
Six things, and they have to share one patient record: protocol-driven charting with dose titration, e-prescribing with a refill cadence, monthly program billing that behaves like a membership, payment routing that keeps medication charges off ordinary retail rails, a patient app for weigh-ins and injection-day reminders, and reporting that can answer “is this program working” with numbers.
| Capability | Why GLP-1 specifically | What to check in the demo |
|---|---|---|
| Titration protocols | Semaglutide and tirzepatide run on stepped dose schedules over months. The chart should carry the schedule, not reconstruct it from prose notes. | Chart week 1 at a starting dose; ask the system what week 9 should be and when the step-up is due. |
| Refill cadence | Every patient needs a refill roughly every 28 days. At 200 patients that is ten refills a business day, forever. | Show the queue of refills due this week, and how one approval sends the script and notifies the patient. |
| Program billing | Most GLP-1 practices bill a flat monthly program fee, not per visit. | Set up a monthly plan, pause it, resume it, and show what happens when a card declines. |
| Payment routing | Mainstream processors prohibit prescription medication sales and enforce by freezing accounts. | Charge a visit and a medication on one checkout and show which rail each settles on. |
| Patient check-ins | Weekly weight, side-effects and injection confirmation are the clinical signal between visits. | Show a patient submitting a weigh-in from their phone and where it lands in the chart. |
| Outcome reporting | Percent body-weight change is the number the whole program is judged on. | Produce average weight change at 3 and 6 months across the panel, without an export. |
If a platform can do those six from one record, the rest — scheduling, intake, messaging — is table stakes it almost certainly also has.
2. Why do GLP-1 clinics lose their payment processing?
Because standard card processors prohibit prescription medication sales in their terms, and enforcement is automated. The account is reviewed or frozen — commonly with a balance inside — and it tends to happen months in, once volume makes the pattern visible, not on day one.
This is not a judgement about the medicine; it is a risk model built for ordinary retail, applied to a business it was never underwritten for. The structural answer is routing: everyday revenue (visits, memberships, retail) runs on an ordinary processor, and medication charges run on rails underwritten for prescription commerce. Good software enforces that split in the checkout rather than leaving it to a policy document.
We wrote the full mechanics up separately, including what the terms actually say: why mainstream processors shut down GLP-1 and TRT clinics.
3. How does prescribing work in GLP-1 clinic software?
GLP-1 medications are not controlled substances, which makes the workflow simpler than a TRT practice’s — no EPCS two-factor signing, no PDMP checks for the GLP-1 scripts themselves. The requirements that remain are workflow requirements: prescribe from inside the chart so the script and the protocol stay in one record, and manage the refill queue as a daily operational surface rather than an inbox.
Two cautions belong in every evaluation. First, if the same practice also prescribes testosterone or other controlled substances, EPCS enters the picture there — check that the platform’s prescribing path supports it rather than assuming. Second, sourcing: brand-name pens versus compounded formulations is a commercial and regulatory question that has moved repeatedly, and any software decision that only works under one sourcing model is fragile. The software’s job is the same either way — the script, the refill cadence and the record.
4. How should a GLP-1 program be billed — membership or per visit?
Most programs converge on a flat monthly fee, because the care itself is monthly. A subscription-shaped program needs subscription-shaped software, and this is where general medical EMRs fail quietly: they can invoice a visit, but they cannot run a plan.
| Billing model | Where it fits | What the software must do |
|---|---|---|
| Monthly program fee | The default for medication-inclusive or management-fee programs. | Auto-renewal, card-on-file, failed-payment retries, pause and resume, proration on plan changes. |
| Per-visit + medication | Lower-volume practices adding GLP-1 to an existing service menu. | Split routing on one checkout; the med charge and the visit charge settle on different rails. |
| Hybrid (fee + med at cost) | Practices separating clinical fees from drug pass-through for transparency. | Two line items, two rails, one receipt — and reporting that keeps them distinguishable. |
Whichever model, one rule from the payments section carries over: the statement descriptor should carry the clinic’s name, never a medication name. A drug name on a card statement is a privacy problem and a dispute magnet at the same time.
5. What should the patient app do for a GLP-1 program?
Carry the week, not just the appointment. The clinical events of a GLP-1 program mostly happen at home: the weekly injection, the daily scale, the nausea that decides whether the next step-up happens on schedule.
The app earns its place if a patient can: log weight and see their own trend line; get the injection-day reminder and confirm the dose; report side-effects in a structured way a provider can triage; request the refill instead of phoning; message the clinic somewhere HIPAA-appropriate rather than by SMS; and pay the program fee without a front-desk call. Each of those is one fewer phone call per patient per month — at a few hundred patients, that is a staff position.
Branding matters more than it looks: a program a patient carries on their phone under the clinic’s own name reads as the clinic’s program. White-labeling is commonly a paid add-on across the market, so price it during evaluation, not after.
6. Can a GLP-1 clinic run fully by telehealth?
Many do — GLP-1 therapy is not a controlled substance, so the federal telemedicine restrictions that complicate TRT do not apply to it. What remains is state law: the prescriber must be licensed in the patient’s state, the state’s good-faith-exam rules decide what the first visit must include, and a few states regulate weight-loss prescribing specifically.
The software consequence is licensure matching: the system should know which states each prescriber holds and refuse to book or route a patient to a prescriber who cannot lawfully treat them. Done in software, that is a non-event; done on trust, it is a board complaint waiting for volume. Labs still happen in the physical world — a telehealth program needs draw-site ordering and results that return into the chart rather than a PDF inbox.
7. The checklist to run against any GLP-1 software vendor
Bring one real patient journey to the demo and make the vendor walk it end to end. Ask in this order, and watch what gets skipped:
| # | Ask for this | What it proves |
|---|---|---|
| 1 | Enroll a patient into a monthly program with a starting dose and a titration schedule. | Protocols are data, not prose. |
| 2 | Show this week’s refill queue and approve one refill. | The recurring workload has a surface. |
| 3 | Charge a visit and a medication in one checkout; show which rail each settled on. | Prescription-safe routing is enforced, not promised. |
| 4 | Submit a weigh-in and a side-effect report from the patient’s phone. | The between-visit signal reaches the chart. |
| 5 | Pause the membership for a month, then resume it. | The billing engine matches how programs really run. |
| 6 | Report average percent weight change at 3 and 6 months. | Outcomes are answerable without a spreadsheet. |
| 7 | Try to route a patient to a prescriber not licensed in their state. | Licensure matching is enforced in software. |
If you are earlier in the journey — deciding whether to open at all — start with how to start a medical weight loss clinic. If you are comparing charting platforms broadly, the shortlist lives at best EHR for medical weight loss clinics.
8. Frequently asked questions
What is the best software for a GLP-1 clinic?
The one that runs the monthly loop from one record: titration protocol, refill queue, membership billing, prescription-safe payment routing, patient check-ins and outcome reporting. Evaluate on that loop rather than on feature-list length — the seven-step demo checklist above is the fastest way to separate platforms that run programs from platforms that book appointments.
Can I run a GLP-1 clinic on Stripe or Square?
Not for the medication charges. Mainstream processors prohibit prescription medication sales in their terms and enforce with account freezes, typically after volume builds. Visits and retail are fine on ordinary rails; medication revenue needs processing underwritten for prescription commerce, and the split should be enforced by the checkout software.
Is semaglutide a controlled substance?
No — GLP-1 medications like semaglutide and tirzepatide are not federally scheduled, so prescribing them does not require EPCS two-factor signing or PDMP checks. If the same practice prescribes testosterone, that is Schedule III and EPCS applies there.
What does GLP-1 clinic software cost?
Purpose-built clinical platforms commonly run $150–600 a month depending on prescriber count — Aminova publishes $199/mo for one prescriber with unlimited support staff. Card processing is usually the bigger number: at roughly 3% of revenue, a program billing $80,000 a month pays about $2,400 in processing, so compare rails and rates before subscriptions.
Do I need LegitScript certification for a GLP-1 clinic?
You need it when you advertise prescription services on major ad platforms or sell prescription products through your website — published pricing as of August 2026 is $975 per website as a one-time application fee plus $2,150 per website annually. A clinic taking payments inside its clinical software, without prescription e-commerce on the public site, is a different posture — but confirm against your processor’s and ad platform’s current requirements.
Is this guide independent?
No — Aminova publishes it and sells software in this category, which is why the disclosure sits at the top rather than the bottom. Every requirement is written to be testable against any vendor, including us.